127 related articles for article (PubMed ID: 20980958)
1. Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D.
Tkacova R; McWilliams A; Lam S; Sin DD
Med Sci Monit; 2010 Nov; 16(11):CR540-4. PubMed ID: 20980958
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein D: a lung specific biomarker in COPD?
Sin DD; Pahlavan PS; Man SF
Ther Adv Respir Dis; 2008 Apr; 2(2):65-74. PubMed ID: 19124360
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
4. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls.
Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM
Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker.
Glas J; Beynon V; Bachstein B; Steckenbiller J; Manolis V; Euba A; Müller-Myhsok B; Folwaczny M
Tissue Antigens; 2008 Jul; 72(1):21-8. PubMed ID: 18498293
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein D in human lung diseases.
Hartl D; Griese M
Eur J Clin Invest; 2006 Jun; 36(6):423-35. PubMed ID: 16684127
[TBL] [Abstract][Full Text] [Related]
8. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
[TBL] [Abstract][Full Text] [Related]
10. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
12. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
[TBL] [Abstract][Full Text] [Related]
13. Serum surfactant protein D is increased in acute and chronic inflammation in mice.
Fujita M; Shannon JM; Ouchi H; Voelker DR; Nakanishi Y; Mason RJ
Cytokine; 2005 Jul; 31(1):25-33. PubMed ID: 15967375
[TBL] [Abstract][Full Text] [Related]
14. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
16. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
17. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality.
Hill J; Heslop C; Man SF; Frohlich J; Connett JE; Anthonisen NR; Wise RA; Tashkin DP; Sin DD
Eur Heart J; 2011 Aug; 32(15):1918-25. PubMed ID: 21653561
[TBL] [Abstract][Full Text] [Related]
18. Unifying thoracic biomarkers: surfactant protein-D and beyond.
Jaw JE; Sin DD
Expert Rev Respir Med; 2012 Apr; 6(2):147-54. PubMed ID: 22455487
[TBL] [Abstract][Full Text] [Related]
19. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease.
Miller YE; Blatchford P; Hyun DS; Keith RL; Kennedy TC; Wolf H; Byers T; Bunn PA; Lewis MT; Franklin WA; Hirsch FR; Kittelson J
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2425-31. PubMed ID: 18006932
[TBL] [Abstract][Full Text] [Related]
20. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid.
Betsuyaku T; Kuroki Y; Nagai K; Nasuhara Y; Nishimura M
Eur Respir J; 2004 Dec; 24(6):964-70. PubMed ID: 15572540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
